Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells  by Koide, Masanobu et al.
Volume 318, number 3, 213-217 FEBS 12158 
0 1993 Federation of European Biochemical Societies 00145793/93/S6.00 
March 1993 
Cytokine-induced expression of an inducible type of nitric oxide synthase 
gene in cultured vascular smooth muscle cells 
Masanobu Koide, Yasuhiro Kawahara, Terutaka Tsuda and Mitsuhiro Yokoyama 
Department of Internal Medicine (1st Division), Kobe University School of Medicine, Kobe 650, Japan 
Received 14 December 1992; revised version received 17 January 1993 
In unstimulated cultured vascular smooth muscle cells (VSMC), mRNA of an inducible macrophage-type of nitric oxide synthase (iNOS) was barely 
detectable. Interferon y (IFNy) and tumor necrosis factor a (TNFcc) markedly increased iNOS mRNA levels in time- and dose-dependent manners. 
The induction of iNOS mRNA paralleled the cytokine-induced nitrite production. Actinomycin D abolished the IFNp and TNFa-induced 
increases in iNOS mRNA and nitrite production. Cycloheximide, which abolished both the IFNy- and TNFcc-induced increases in nitrite 
production, had no effect on the IFNy-induced increase in iNOS mRNA but markedly inhibited the TNFa-induced one. These results suggest 
that IFNy directly induces the expression of the iNOS gene whereas TNFa mainly induces it via the induction of an intermediary protein in cultured 
VSMC. 
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1. INTRODUCTION 
NO accounts for many of the biological properties of 
endothelium-derived relaxing factor such as relaxation 
of vascular smooth muscle and inhibition of platelet 
adhesion and aggregation via the activation of soluble 
guanylate cyclase [1,2]. NO is synthesized by oxidation 
of the terminal guanidino-nitrogen atom(s) of L-argin- 
ine by a family of enzymes called the NOS [3]. At least 
three distinct types of NOS have been identified: a con- 
stitutive Ca2’- and calmodulin-dependent cytosolic 
form which is present in the brain, platelets and adrenal 
glands, a constitutive Ca2’- and calmodulin-dependent 
membrane-bound form which is present in endothelial 
cells and an inducible Ca2’-independent form which is 
present in macrophages, hepatocytes, mesangial cells 
and endothelial cells only after the treatment with en- 
dotoxin or certain cytokines such as ILl, TNFol or 
IFNy [ 1,2,4]. The inducible form of NOS activity is also 
induced in rat aortic rings and in cultured VSMC by 
cytokines and endotoxin [5,6], which is suggested to be 
responsible for the loss of vascular responsiveness ob- 
served in septic shock and during antitumor therapy 
with TNFa [7]. Moreover, it has recently been demon- 
strated that in vivo balloon injury locally induces NOS 
activity in rat carotid arteries [8]. Therefore, it is possi- 
ble that the NOS induction in VSMC plays some role 
not only in the pathogenesis of septic shock but also in 
local vascular inflammatory lesions such as vasculitis, 
atherosclerosis and arterial injury following ballooning 
angioplasty where macrophages and T lymphocytes ac- 
cumulate and release the cytokines. 
The biochemical and pharmacological experiments 
described above strongly suggest that the cytokines in- 
duce the expression of the iNOS gene. In these experi- 
ments, however, the expression of iNOS is demon- 
strated only by the generation of cyclic GMP, the sec- 
ond messenger of NO, and nitrite, a stable oxidative 
metabolite of NO. Thus, it is not obvious whether these 
cytokines directly induce the expression of the iNOS 
gene or act via the induction of an intermediary protein. 
In the present study, we demonstrate for the first time 
that IFNy and TNFa increase iNOS mRNA levels in 
VSMC. We also provide evidence that IFNy directly 
induces the increase in iNOS mRNA but that TNFa 
induces it mainly through a newly synthesized protein 
intermediate. 
2. MATERIALS AND METHODS 
Correspondence address: Y. Kawahara, Department of Internal Med- 
icine (1st Division), Kobe University School of Medicine, 7-S-l Ku- 
sunoki-cho, Chuo-ku, Kobe 650, Japan. Fax: (81) (78) 341 1390. 
2. I. Materials 
Abbreviations: NO, nitric oxide; NOS, nitric oxide synthase; ILI, in- 
terleukin 1; TNFa, tumor necrosis factor a; IFNy, interferon y; 
VSMC, vascular smooth muscle cells; iNOS, inducible nitric oxide 
synthase; LPS, lipopolysaccharide; GAPDH, glyceraldehyde-3-phos- 
phate dehydrogenase. 
VSMC were isolated from rat thoracic aorta by enzymatic dissocia- 
tion as described previously [9] and used at passage levels 9-16. The 
mouse monocyte-macrophage c ll line J774A. I was obtained from the 
Japanese Cancer Research Resources Bank. Recombinant mouse 
IFNy and TNFa were purchased from Genzyme, Cambridge, MA, 
USA. LPS (from E. coli 055:B5) was from Sigma, St. Louis, MO, 
USA. [a-‘*P]dCTP (3.000 Wmmol) was from Amersham Japan, 
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Tokyo, Japan. GAPDH cDNA was gifted from Dr. K. Sane, Kobe 
University School of Medicine, Kobe, Japan. cDNA for a constitutive 
brain-type of NOS was a generous gift of Drs. D.S. Bredt and S.H. 
Snyder, Johns Hopkins University School of Medicine, Baltimore. 
MD, USA. Other matenals and chemicals were obtained from com- 
mercial sources. 
2.2. Preparation of cDNA probe for iNOS 
RNA prepared from IFNy plus LPS-stimulated J774A. 1 cells was 
reverse transcribed into cDNA. A polymerase chain reaction was used 
to amplify a 1,033-base pair iNOS cDNA fragment. The sequences of 
the forward (ACAGGGAAGTCTGAAGCACTAG) and reverse 
(CATGCAAGGAAGGGAACTCTTC) primers were based on the 
published tNOS cDNA sequence (nucleotides 1,621&2.653) [lO,ll]. 
Authenticity of the polymerase chain reaction product was confirmed 
by sequencing by the dye primer method using an Applied Biosystems 
DNA sequencer model 373A (Applied Biosystems Japan, Inc., Tokyo, 
Japan). 
2.3. RNA extraction and Northern blottrng 
Total RNA was extracted by the method of Chomczynski and 
Sacchi [12]. Total RNA (3Opg per lane) was subjected to electropho- 
resis on 1% agarose gels containing formaldehyde and transferred to 
nitrocellulose filters. The filters were hybridized with a random 
primed, “P-1abelled iNOS cDNA probe for 20 h. The hybridized filters 
were then washed twice with 150 mM NaCI, 15 mM sodium citrate, 
and 0.1% sodium dodecyl sulfate at 65°C and analyzed using a FUJIX 
bio-imaging analyzer BAS2000 (Fuji Photo Film Co. Ltd., Tokyo, 
Japan). The filters were subsequently stripped and rehybridized with 
a “P-1abelled GAPDH cDNA probe. 
2.4. Measurement of nitrite 
Nitrite was measured by mixing 500 ~1 of the medium with an equal 
volume of Griess reagent (1 part 0.1% naphthylethylenediamine dihy- 
drochloride to 1 part 1% sulfanilamide in 5% phosphoric acid) [13]. 
The absorbance at 550 nm was measured and nitrite concentration was 
determined using a curve calibrated from sodium nitrite standards. 
Data were normalized to the protein content of VSMC in each dish. 
A 
TNFa 
3. RESULTS 
To examine whether IFNy and TNFa cause the in- 
duction of iNOS mRNA, total RNA prepared from 
VSMC treated with IFNy or TNFcl was analyzed by 
Northern blotting. iNOS mRNA was barely detectable 
in total RNA prepared from control VSMC. Treatment 
of the cells with IFNy and TNFcl induced marked in- 
creases in iNOS mRNA in similar time courses (Fig. 
1A). Levels of iNOS mRNA significantly increased 
within 6 h and continued to increase for at least 30 h 
after exposure to either IFNy or TNFa. The most 
prominent transcript is about 5.0 kb in length and two 
larger transcripts were also detected after prolonged 
exposure of autoradiography. The pattern of these tran- 
scripts was similar to that reported in activated macro- 
phages [lo]. When Northern blots were probed with 
GAPDH cDNA, a single message was detected at about 
1.4 kb. The intensities of hybridization of the GAPDH 
cDNA to RNA were equal among all lanes, verifying 
that equal amounts of RNA were loaded per lane and 
that the observed induction of iNOS mRNA was not 
due to a generalized effect on the mRNA content in the 
cells. Time courses of nitrite accumulation induced by 
IFNy and TNFa correlated well with those of the in- 
duction of iNOS mRNA (Fig. 1B). Levels of nitrite 
accumulated in the medium significantly increased 
within 6 h and continued to increase for at least 30 h 
after exposure to either IFNy or TNFa. In another set 
of experiments, we also investigated mRNA levels of the 
constitutive brain type of NOS in VSMC as well as in 
various rat tissues. We observed a clear expression of 
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Fig. 1. (A) Time courses of the iNOS mRNA Induction by 1FNy and TNFa. VSMC were stimulated with 100 units/ml IFNy (left panel) or 100 
t&ml TNFa (right panel) for various periods of time as mdicated. Total RNA was isolated and analyzed by Northern blotting with iNOS (upper 
panel) and GAPDH (lower panel) cDNA probes. The positions of the 28 S and 18 S ribosomal RNA subunits are indicated at the right. The 
experiment shown represents one of three Independent trials which gave nearly identical results. (B) Time courses of the nitrite production by IFNy 
and TNFa. VSMC were stimulated with 100 units/ml IFNy (c) or 100 ng/ml TN Fa (0) for various periods of time as Indicated. Nitrite concentration 
m the culture medium was mcasurcd Polrnts and bars represent the mean f S.E.M (n = 3). 
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its mRNA in the cerebellum and adrenal glands but 
could not detect it in VSMC before or after exposure to 
the cytokines (data not shown), suggesting that IFNy 
and TNFa specifically induce the expression of the 
iNOS gene in VSMC. Fig. 2A shows dose-response 
relationships of the IFNy- and TNFa-induced increases 
in iNOS mRNA. The dose dependencies of the IFNy- 
and TNFa-stimulated nitrite accumulation were similar 
to those of the IFNy- and TNFa-stimulated induction 
of iNOS mRNA, respectively (Fig. 2B). 
We next investigated the effects of actinomycin D, an 
inhibitor of DNA-dependent RNA transcription, or cy- 
cloheximide, an inhibitor of protein synthesis on the 
IFNy- and TNFa-induced increases in iNOS mRNA 
and nitrite accumulation. As shown in Fig. 3, actinomy- 
tin D had no effect on the basal levels of iNOS mRNA 
and nitrite production. When actinomycin D was given 
in concert with IFNy or TNFa, the IFNy- and TNFa- 
stimulated increases in iNOS mRNA levels as well as 
nitrite accumulation were abolished, suggesting that 
0 0.1 1 10 100 1000 
u/ml 
TNFa 
these cytokines regulate iNOS activity at the level of 
iNOS gene transcription. Although the basal level of 
iNOS mRNA was slightly elevated by cycloheximide, 
the induction of iNOS mRNA by IFNy was virtually 
unaffected by cycloheximide, indicating that the in- 
crease in iNOS mRNA is a primary response to IFNy. 
Under the same conditions, cycloheximide markedly 
inhibited the TNFcx-induced increase in iNOS mRNA, 
suggesting that the TNFa-induced increase in iNOS 
mRNA requires de novo protein synthesis. Cyclo- 
heximide completely inhibited the IFNy- and TNFol- 
induced nitrite accumulation, confirming the effective- 
ness of our preparation of cycloheximide. 
4. DISCUSSION 
In the present study, we demonstrated for the first 
time that IFNy and TNFol increase iNOS mRNA levels 
in VSMC. Since the induction of iNOS mRNA by IFNy 
was unaffected by cycloheximide, expression of the 
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Fig. 2. (A) Dose-response relationships of the IFNy- and TNFa-stimulated iNOS mRNA induction. VSMC were stimulated for 24 h with various 
concentrations of IFNy (left panel) and TNFa (right panel) as indicated. Total RNA was isolated and analyzed by Northern blotting with iNOS 
(upper panel) and GAPDH (lower panel) cDNA probes. The positions of the 28 S and 18 S ribosomal RNA subunits are indicated at the right. 
The experiment shown represents one of three independent trials which gave nearly identical results. (B) Dose-response curves of the IFNy- and 
TNFcc-stimulated nitrite production. VSMC were stimulated for 24 h with various concentrations of IFNy (left panel) and TNFa (right panel) 
as indicated. Nitrite concentration in the culture medium was measured. Points and bars represent he mean f S.E.M. (n = 3). 
215 
Volume 3 18, number 3 FEBS LETTERS March 1993 
A B 
Control Cycloheximide Actinomycin D 
Cycloheximide Adinomycin D 
Fig. 3. (A) Effects of cycloheximide and actinomycin D on the cytokine-induced increases in iNOS mRNA. VSMC were preincubated with 20&/ml 
cycloheximrde, 2 ,@ml actinomycin D or their vehicle for 1 h and incubated with 100 units/ml IFNy, 100 ng/ml TNFa or their vehicle for an 
additional 24 h in the presence of the metabolic inhibitors. Total RNA was isolated and analyzed by Northern blotting with iNOS (upper panel) 
and GAPDH (lower panel) cDNA probes. The positions of the 28 S and 18 S ribosomal RNA subunits are indicated at the right. The experiment 
shown represents one of four independent rials which gave nearly identical results. (B) Effects of cycloheximide and actinomycin D on the 
cytokine-induced nitrite production. VSMC were preincubated with 20 &ml cyclohextmide, 2 j&ml actinomycin D or their vehicle for I h and 
incubated with 100 units/ml IFNy, 100 ng/ml TNFa or their vehicle for an additional 24 h in the presence of the metabolic inhibitors. Nitrite 
concentration in the culture medium was measured. Points and bars represent he mean f S.E.M. (n = 4). 
iNOS gene appears to be directly regulated by IFNy. 
Interferons including IFNy directly stimulate the ex- 
pression of a number of genes and many of them have 
been shown to possess a common DNA element, inter- 
feron response sequence, which is usually present in the 
5’-upstream region of these genes [14]. It is possible that 
the iNOS gene is one of the members of an interferon- 
inducible gene family. It remains to be clarified whether 
interferon response sequence is also present in the 5’- 
upstream region of the iNOS gene. On the other hand, 
the marked inhibition by cycloheximide of the TNFa- 
induced increase in iNOS mRNA suggests that TNFa 
induces a protein which in turn induces the increase in 
iNOS mRNA. TNFa has been shown to cause accumu- 
lation of IL1 mRNA in human VSMC and subsequent 
release of IL1 from them [ 151. Since IL1 has been shown 
to induce NO production in VSMC [6], it is possible that 
TNFcl increases iNOS mRNA levels via the induction 
of ILl. However, we cannot completely rule out the 
possibility that the inhibitory effect of cycloheximide on 
the TNFa-induced increase in iNOS mRNA is due to 
a potentiative effect of cycloheximide on a cytotoxic 
effect of TNFa. But this possibility seems unlikely 
based on the following observations. Although the cells 
appeared to be damaged to some extent after the pro- 
longed exposure to cycloheximide, there was no differ- 
ence in the extent of cellular damage between the cells 
treated with TNFcx plus cycloheximide and IFNy plus 
cycloheximide as assessed by trypan blue exclusion. 
Moreover, there was no difference in the amounts of 
216 
total RNA and GAPDH mRNA per dish between those 
cells. Further studies are obviously needed to deny this 
possibility and identify the intermediary protein in- 
volved in the TNFa-induced increase in iNOS mRNA. 
IFNy is produced by activated T lymphocytes and 
exerts antiviral, immunomodulatory and antiprolifera- 
tive activities for various cells [16]. TNFa: is produced 
by activated macrophages and VSMC and exerts tu- 
moricidal, immunomodulatory and proliferative activi- 
ties for various cells [16,17]. For VSMC, IFNy inhibits 
cell proliferation in a cell culture system [16] and sup- 
presses the development of intimal thickening of rat 
carotid arteries induced by in vivo balloon injury [18]. 
TNFa also acts on VSMC and induces prostaglandin 
E2 release [151 as well as IL1 production. Immunohisto- 
chemical studies have clearly shown that activated T 
lymphocytes and macrophages are present in athero- 
sclerotic lesions and lesions after vascular injury 
[ 16,19,20]. Immunoreactive IFNy and TNFcl proteins 
have also been detected within human atherosclerotic 
lesions [19]. Recently, Joly et al. have reported that in 
vivo balloon injury induces NOS activity in rat carotid 
arteries [8]. Therefore, it is very likely that, via the in- 
duction of iNOS in VSMC, IFNy and TNFa locally 
released within atherosclerotic or vascular injured le- 
sions may play some roles such as a vasorelaxing activ- 
ity which counteracts the vasoconstrictive properties of 
atherosclerotic arteries. They might also provide an 
anti-thrombogenic activity for exposed VSMC after en- 
dothelial denudation by ballooning angioplasty. Previ- 
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ously, we and others have reported that NO-generating 
vasodilators inhibit the proliferation of VSMC [21,22]. 
Very recently, Nunokawa and Tanaka have provided 
evidence suggesting that IFNy inhibits the proliferation 
of VSMC via NO production by iNOS [23]. Thus, it is 
also possible that, via the induction of iNOS in VSMC, 
IFNy and TNFo! inhibit the proliferation of VSMC 
within atherosclerotic and vascular injured lesions. 
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